Parexel to be acquired by PE in $5bn deal 20-Jun-2017 By Melissa Fassbender Parexel International Corporation has signed a definite agreement to be acquired by the private equity firm Pamplona Capital Management, LLP.
Parexel to lay off 850 amid restructuring 25-Jun-2015 By Zachary Brennan Massachusetts-based CRO Parexel is eliminating 850 positions, which it expects will cost the company $30m to $40m in employee separation benefits.
Parexel CEO reflects on Pfizer deal 06-Jun-2011 By Gareth Macdonald Parexel CEO Josef von Rickenbach predicts more Big Pharma strategic partnerships.
Clinical trials globalisation strengthens Parexel Clinical trials globalisation strengthens Parexel 23-Jan-2007 By Emilie Reymond There are currently three key market trends that play to Parexel's strengths and one of them is the globalisation of clinical trials, the company's CEO claimed during a healthcare conference earlier this month.
